Ophthalmic Lasers - Medical Devices Pipeline Assessment, 2017

Ophthalmic Lasers - Medical Devices Pipeline Assessment, 2017

Summary

GlobalDatas Medical Devices sector report, Ophthalmic Lasers - Medical Devices Pipeline Assessment, 2017" provides an overview of Ophthalmic Lasers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Lasers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Ophthalmic Lasers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ophthalmic Lasers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ophthalmic Lasers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

2 Introduction 7
2.1 Ophthalmic Lasers Overview 7
3 Products under Development 8
3.1 Ophthalmic Lasers - Pipeline Products by Stage of Development 8
3.2 Ophthalmic Lasers - Pipeline Products by Segment 9
3.3 Ophthalmic Lasers - Pipeline Products by Territory 10
3.4 Ophthalmic Lasers - Pipeline Products by Regulatory Path 11
3.5 Ophthalmic Lasers - Pipeline Products by Estimated Approval Date 12
3.6 Ophthalmic Lasers - Ongoing Clinical Trials 13
4 Ophthalmic Lasers - Pipeline Products under Development by Companies 14
4.1 Ophthalmic Lasers Companies - Pipeline Products by Stage of Development 14
4.2 Ophthalmic Lasers - Pipeline Products by Stage of Development 15
5 Ophthalmic Lasers Companies and Product Overview 16
5.1 3D-Micromac AG Company Overview 16
5.1.1 3D-Micromac AG Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Alcon Inc Company Overview 17
5.2.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Bausch & Lomb Inc Company Overview 18
5.3.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Bausch + Lomb Technolas Company Overview 21
5.4.1 Bausch + Lomb Technolas Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Belkin Laser Ltd Company Overview 23
5.5.1 Belkin Laser Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Biolase, Inc. Company Overview 25
5.6.1 Biolase, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.7 Carl Zeiss Meditec AG Company Overview 26
5.7.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 26
5.8 CV Laser Pty Ltd Company Overview 27
5.8.1 CV Laser Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
5.9 Ellex Medical Lasers Limited Company Overview 28
5.9.1 Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview 28
5.10 IOPtima Ltd. Company Overview 30
5.10.1 IOPtima Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 Lensar Inc Company Overview 31
5.11.1 Lensar Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 LumiThera, Inc. Company Overview 32
5.12.1 LumiThera, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 Massachusetts Eye and Ear Infirmary Company Overview 34
5.13.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 34
5.14 Michigan State University Company Overview 35
5.14.1 Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 MRC Systems GmbH Company Overview 36
5.15.1 MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 36
5.16 Nidek Co Ltd Company Overview 37
5.16.1 Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
5.17 Princeton University Company Overview 38
5.17.1 Princeton University Pipeline Products & Ongoing Clinical Trials Overview 38
5.18 Rowiak GmbH Company Overview 39
5.18.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview 39
5.19 Spire Corp Company Overview 40
5.19.1 Spire Corp Pipeline Products & Ongoing Clinical Trials Overview 40
5.20 Stroma Medical Corp Company Overview 41
5.20.1 Stroma Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 41
5.21 University of Bern Company Overview 42
5.21.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview 42
5.22 University of Calgary Company Overview 43
5.22.1 University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 43
5.23 Visioneering Technologies Inc Company Overview 44
5.23.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44
6 Ophthalmic Lasers- Recent Developments 45
6.1 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 45
6.2 May 11, 2017: ZEISS: Significant Growth in Revenue and Earnings 45
6.3 May 10, 2017: LENSAR Awards Teleon Surgical European Distributor Contract 46
6.4 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 47
6.5 May 08, 2017: ZEISS Appoints New Fellow 48
6.6 May 08, 2017: Dr. Stephen S. Lane joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy 49
6.7 May 05, 2017: LENSAR Receives FDA Clearances for Laser Cataract Platform Integration With OCULUS Pentacam Tomographers 50
6.8 May 05, 2017: BIOLASE Announces Management Change 51
6.9 May 04, 2017: IRIDEX Announces Presentation Of Data Demonstrating Safety And Efficacy Of Micropulse Technology At Upcoming Industry Conferences 51
6.10 May 03, 2017: IRIDEX Announces First Quarter 2017 Financial Results 52
6.11 May 03, 2017: BIOLASE Reports 2017 First Quarter Results 53
6.12 Apr 25, 2017: Novartis delivered sales growth across all divisions as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued 54
6.13 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 59
6.14 Mar 21, 2017: Dr. Tom Tooma Performs ReLEx SMILE Procedures for Correction of Myopia in Orange County 59
6.15 Mar 21, 2017: Dieter Kurz Confirmed as Chairman of the Supervisory Boards at SCHOTT and ZEISS 59
6.16 Mar 13, 2017: BIOLASE Names James D. Surek Vice President Sales, Americas 60
6.17 Mar 08, 2017: BIOLASE Reports 2016 Full Year and Fourth Quarter Results 60
6.18 Mar 08, 2017: IRIDEX Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial Outlook 63
6.19 Mar 01, 2017: BIOLASE Names Mark J. Nelson Chief Financial Officer 64
6.20 Feb 28, 2017: Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting 65
6.21 Feb 27, 2017: Ellex Medical Lasers: Financial Report for Half-Year Ended 31 December 2016 66
6.22 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 67
6.23 Feb 02, 2017: Ellex Trading Update for the Six Months Ended 31 December 2016 68
6.24 Jan 26, 2017: LENSAR Launches Streamline III to Assist Cataract Surgeons in Managing and Improving Astigmatism Treatment for Optimal Visual Outcomes 70
6.25 Jan 26, 2017: Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report 70
6.26 Jan 26, 2017: Achievement of sales milestone for COPD products 71
6.27 Jan 25, 2017: Novartis delivered solid 2016 performance, with Growth Products absorbing Gleevec US LOE; innovation momentum continued; announces share buyback 72
6.28 Jan 17, 2017: Visioneering Technologies Announces Jeff Babbe as New Executive Territory Manager for Chicago, IL 79
6.29 Jan 09, 2017: BIOLASE Announces Management Change 79
6.30 Jan 09, 2017: IRIDEX Announces Preliminary Unaudited Revenues for 2016 Fourth Quarter and Full Year 79
6.31 Jan 06, 2017: NIDEK launches the YLC-500 Vixi Yellow Scan Laser Photocoagulator / YLC-500 Yellow Laser Photocoagulator 80
6.32 Dec 21, 2016: Visioneering Technologies Announces Brian Atkinson as Territory Manager for the Dallas/Ft. Worth Market 80
6.33 Dec 19, 2016: Lensar Strategic Restructure In Partnership With Pdl Biopharma 81
6.34 Dec 16, 2016: ZEISS Achieves Record Revenue and Earnings 81
6.35 Dec 13, 2016: Visioneering Technologies Announces Ken Gold as New Executive Territory Manager for the Baltimore-Washington, DC Area 83
6.36 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend 83
6.37 Dec 07, 2016: VTI names executive director of manufacturing and engineering 84
6.38 Dec 07, 2016: Visioneering Technologies Announces Ms. Rosa Lee as New Executive Director of Manufacturing & Engineering 85
6.39 Dec 01, 2016: Compact Navilas Laser System 577s Receives U.S. FDA Clearance 85
6.40 Nov 29, 2016: Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda 86
6.41 Nov 16, 2016: New Head of the ZEISS Semiconductor Manufacturing Technology Business Group 87
6.42 Nov 09, 2016: Daniel B. Polley, Ph.D., appointed Director of Lauer Tinnitus Research Center at Mass. Eye and Ear 88
6.43 Nov 08, 2016: BIOLASE Reports 2016 Third Quarter and Nine-Month Results 89
6.44 Nov 03, 2016: IRIDEX Reports 2016 Third Quarter, Nine-Month Results 91
6.45 Oct 25, 2016: Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters 92
6.46 Oct 18, 2016: New laser eye procedure receives FDA approval - something to SMILE about! 99
6.47 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 100
6.48 Oct 12, 2016: Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago 101
6.49 Oct 11, 2016: IRIDEX Announces Preliminary Revenues for 2016 Third Quarter 103
6.50 Oct 04, 2016: Zecotek Announces Preliminary Revenue for Fiscal 2016 103
6.51 Sep 14, 2016: ZEISS receives US FDA Approval for VisuMax SMILE vision correction procedure, the latest advancement in laser eye surgery 104
6.52 Sep 13, 2016: FDA approves VisuMax Femtosecond Laser to surgically treat nearsightedness 105
6.53 Aug 26, 2016: Ellex awarded $2.5m Federal Government Grant 106
6.54 Aug 26, 2016: Ellex Reports Full Year FY16 Audited Results 106
6.55 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery 107
6.56 Aug 04, 2016: IRIDEX Reports 2016 Second Quarter, Six-Month Results 108
6.57 Aug 01, 2016: BIOLASE Reports 2016 Second Quarter and Six-Month Results 108
6.58 Jul 28, 2016: Ellex Reports Trading Update for the Year Ended 30 June 2016 111
6.59 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization 112
6.60 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board 112
6.61 Jul 19, 2016: Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects 112
6.62 Jul 11, 2016: IRIDEX Announces Atabak Mokari Will Be Chief Financial Officer And VP Corporate Development 119
6.63 Jul 06, 2016: U.S. patent trial and appeal board grants ZEISS petition and institutes IPR against NPE patent holder AMI 119
6.64 Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance 120
7 Appendix 121
7.1 Methodology 121
7.2 About GlobalData 124
7.3 Contact Us 124
7.4 Disclaimer 124

List Of Tables

Table 1: Ophthalmic Lasers - Pipeline Products by Stage of Development 8
Table 2: Ophthalmic Lasers - Pipeline Products by Segment 9
Table 3: Ophthalmic Lasers - Pipeline Products by Territory 10
Table 4: Ophthalmic Lasers - Pipeline Products by Regulatory Path 11
Table 5: Ophthalmic Lasers - Pipeline Products by Estimated Approval Date 12
Table 6: Ophthalmic Lasers - Ongoing Clinical Trials 13
Table 7: Ophthalmic Lasers Companies - Pipeline Products by Stage of Development 14
Table 8: Ophthalmic Lasers - Pipeline Products by Stage of Development 15
Table 9: 3D-Micromac AG Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Excimer Laser System - Product Status 16
Table 11: Excimer Laser System - Product Description 16
Table 12: Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 17
Table 13: ALLEGRETTO EX-400 Laser - Product Status 17
Table 14: ALLEGRETTO EX-400 Laser - Product Description 17
Table 15: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 16: TECHNOLAS TENEO 317 Excimer Laser - Product Status 18
Table 17: TECHNOLAS TENEO 317 Excimer Laser - Product Description 19
Table 18: Bausch & Lomb Inc - Ongoing Clinical Trials Overview 20
Table 19: TECHNOLAS TENEO 317 Excimer Laser - A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIK 20
Table 20: Bausch + Lomb Technolas Pipeline Products & Ongoing Clinical Trials Overview 21
Table 21: Customlens - Product Status 21
Table 22: Customlens - Product Description 21
Table 23: Customshape - Product Status 22
Table 24: Customshape - Product Description 22
Table 25: Belkin Laser Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
Table 26: BELKIN Laser - Glaucoma - Product Status 23
Table 27: BELKIN Laser - Glaucoma - Product Description 23
Table 28: Belkin Laser Ltd - Ongoing Clinical Trials Overview 24
Table 29: BELKIN Laser - Glaucoma - Direct Selective Laser Trabeculoplasty (DSLT) in Open Angle Glaucoma (OAG): A Randomized Controlled Trial 24
Table 30: Biolase, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 31: YSGG Waterlase Laser - Presbyopia - Product Status 25
Table 32: YSGG Waterlase Laser - Presbyopia - Product Description 25
Table 33: Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 26
Table 34: IRay Stereotactic Radiotherapy System - Product Status 26
Table 35: IRay Stereotactic Radiotherapy System - Product Description 26
Table 36: CV Laser Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
Table 37: Multipurpose Ophthalmic Laser - Product Status 27
Table 38: Multipurpose Ophthalmic Laser - Product Description 27
Table 39: Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview 28
Table 40: Integre Pro Scan - Product Status 28
Table 41: Integre Pro Scan - Product Description 29
Table 42: IOPtima Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 43: IOPtiMate - Product Status 30
Table 44: IOPtiMate - Product Description 30
Table 45: Lensar Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 46: LensAR Laser System - Presbyopia - Product Status 31
Table 47: LensAR Laser System - Presbyopia - Product Description 31
Table 48: LumiThera, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 49: LT-300 LED - Product Status 32
Table 50: LT-300 LED - Product Description 32
Table 51: LumiThera, Inc. - Ongoing Clinical Trials Overview 33
Table 52: LT-300 LED - A Double-masked, Randomized, Sham-controlled, Parallel Group, Single-center Study to Assess the Safety and Efficacy of Photobiomodulation in Subjects with Dry Age-related Macular Degeneration 33
Table 53: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 34
Table 54: Corneal Flap Slicer - Product Status 34
Table 55: Corneal Flap Slicer - Product Description 34
Table 56: Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 35
Table 57: Adaptive Laser System - Product Status 35
Table 58: Adaptive Laser System - Product Description 35
Table 59: MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 36
Table 60: FLIM - Product Status 36
Table 61: FLIM - Product Description 36
Table 62: Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
Table 63: NAVEX Quest - Product Status 37
Table 64: NAVEX Quest - Product Description 37
Table 65: Princeton University Pipeline Products & Ongoing Clinical Trials Overview 38
Table 66: Presbyopia Correction Device - Product Status 38
Table 67: Presbyopia Correction Device - Product Description 38
Table 68: Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview 39
Table 69: LenSurgeon - Presbyopia Reversal - Product Status 39
Table 70: LenSurgeon - Presbyopia Reversal - Product Description 39
Table 71: Spire Corp Pipeline Products & Ongoing Clinical Trials Overview 40
Table 72: Fiber Laser Instrument - Eye Surgery - Product Status 40
Table 73: Fiber Laser Instrument - Eye Surgery - Product Description 40
Table 74: Stroma Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 41
Table 75: Stroma Ophthalmic Device - Eye Color - Product Status 41
Table 76: Stroma Ophthalmic Device - Eye Color - Product Description 41
Table 77: University of Bern Pipeline Products & Ongoing Clinical Trials Overview 42
Table 78: Integrated Computer Assisted Retinal Laser Photocoagulation System - Product Status 42
Table 79: Integrated Computer Assisted Retinal Laser Photocoagulation System - Product Description 42
Table 80: University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 43
Table 81: Opthalmic Laser Device - Product Status 43
Table 82: Opthalmic Laser Device - Product Description 43
Table 83: Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 84: LASIK Device - Product Status 44
Table 85: LASIK Device - Product Description 44
Table 86: Glossary 123

List Of Figures

Figure 1: Ophthalmic Lasers - Pipeline Products by Stage of Development 8
Figure 2: Ophthalmic Lasers - Pipeline Products by Segment 9
Figure 3: Ophthalmic Lasers - Pipeline Products by Territory 10
Figure 4: Ophthalmic Lasers - Pipeline Products by Regulatory Path 11
Figure 5: Ophthalmic Lasers - Pipeline Products by Estimated Approval Date 12
Figure 6: Ophthalmic Lasers - Ongoing Clinical Trials 13

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available